Bronsther to Participate in Panel on Raising Funds in Biotech Oscar L. Bronsther, M.D., CEO of MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and...
Interviews Spotlight Importance of Company’s Diagnostic Tests for Predicting Metastasis in Patients with Breast Cancer MetaStat, Inc. (OTCQB: MTST), a molecular diagnostic company focused...
Thirty Years of Biopharmaceutical Industry Experience Includes Leadership, Development and Commercialization MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on...
-- Company Raises Total Gross Proceeds of $3.4 Million -- MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic...
Research Represents Next Step Forward in Path Toward Commercialization of Company’s Diagnostic Tests MetaStat, Inc. (OTCQB: MTST), a molecular diagnostic company focused on developing and...
MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic tests for early and reliable prediction of systemic...
CEO Oscar L. Bronsther to Present on Tuesday, January 13 at 10:30 AM PT MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing...
Becomes Pure-Play Molecular Diagnostics Company, Focused Exclusively on Developing and Commercializing Epigenetic-based Diagnostic Tests to Determine the Risk of Developing Systemic...
Company’s Diagnostic Tests for Early Detection of Systemic Metastasis Spotlighted in Boston Magazine, Medical Device Daily and MedCity News MetaStat, Inc. (OTCQB:MTST), a molecular...
Decades of Experience Add Strength to Board MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on understanding and treating systemic metastasis, appointed Richard J...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 2292 | 0.0001 | CS |
4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 2292 | 0.0001 | CS |
12 | -0.0001 | -50 | 0.0002 | 0.003 | 0.0001 | 20300 | 0.00114463 | CS |
26 | 0 | 0 | 0.0001 | 0.003 | 0.0001 | 13554 | 0.00110028 | CS |
52 | 0 | 0 | 0.0001 | 0.003 | 0.0001 | 12425 | 0.00110028 | CS |
156 | -0.0029 | -96.6666666667 | 0.003 | 0.003 | 1.0E-6 | 14215 | 0.0005525 | CS |
260 | -0.0173 | -99.4252873563 | 0.0174 | 0.075 | 1.0E-6 | 19511 | 0.00791822 | CS |
銘柄コード | 株価 | 出来高 |
---|---|---|
RDARRaadr Inc (PK) | US$ 0.00095 (5.56%) | 289.48M |
RNVARennova Health Inc (CE) | US$ 0.000001 (0.00%) | 200M |
ASTAAstra Veda Corporation (PK) | US$ 0.0002 (0.00%) | 93.84M |
HCMCHealthier Choices Management Corporation (PK) | US$ 0.000001 (-99.00%) | 88.64M |
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0.00285 (3.64%) | 79.45M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約